Search clinical trials for: Tafamidis meglumine;

Total 131 results

Pfizer

Recruiting

Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

ATTR-CM (Transthyretin Amyloid Cardiomyopathy)

Korea, Republic of
Insel Gruppe AG, University Hospital Bern
Luzerner Kantonsspital; Cantonal Hospital of St. Gallen; Triemli Hospital

Recruiting

Swiss Cardiac Amyloidosis REgistry (Swiss-CARE) (B-CARE)

Amyloid Cardiomyopathy

Switzerland
The Christ Hospital
The Cleveland Clinic; Ohio State University

Recruiting

ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy

Transthyretin Amyloidosis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Hyperbilirubinemia

United States
Pfizer

Completed

A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults

Healthy

Belgium
Pfizer

Active, not recruiting

Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

United States
Pfizer

Completed

A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants

Healthy

Belgium
Pfizer

Completed

Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045. (TRAMA)

Polyneuropathy | Hereditary Transthyretin Amyloidosis (ATTRv)

Spain
Pfizer

Completed

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Transthyretin (TTR) Amyloid Cardiomyopathy

United States, Taiwan, Canada, Belgium, Australia, Czechia, Sweden, Spain, Italy, Hong Kong, Germany, Netherlands, United Kingdom, France, Japan, Argentina, Brazil
Pfizer

Active, not recruiting

A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Transthyretin Amyloid Cardiomyopathy

Korea, Republic of
Postgraduate Institute of Medical Education and...

Active, not recruiting

Deflazacort vs. Prednisolone in Acute-stage ABPA

Allergic Bronchopulmonary Aspergillosis

India
Pfizer

Completed

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Transthyretin Amyloid Cardiomyopathy

China
Pfizer

Completed

This Study Will Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis

Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Patient Blood Management In CARdiac sUrgical patientS (ICARUS)

Iron-deficiency | Anemia | Iron Deficiency Anemia | Iron Deficiency Anemia Treatment | Blood Loss Anemia | Erythropoiesis Abnormal

Italy
Pfizer

Completed

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

ATTR-PN

United States, Germany, Argentina, Brazil, France, Italy, Portugal, Sweden
Pfizer

Completed

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

ATTR-CM | TTR-CM

United States
Pfizer

Completed

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Healthy Volunteers

Belgium
McGill University Health Centre/Research Institute...
ViiV Healthcare; CIHR Canadian HIV Trials Network

Completed

Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations (TRIIADD)

HIV Infections

Canada
Pfizer

Completed

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (ATTR-ACT)

Transthyretin (TTR) Amyloid Cardiomyopathy

United States, Spain, Czechia, Canada, Belgium, Netherlands, Germany, Japan, France, United Kingdom, Brazil, Italy, Sweden
Pfizer

Completed

Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)

Healthy Volunteers

Belgium
Pfizer

Completed

A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood

Healthy

Belgium
Pfizer

Completed

A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood

Healthy

Belgium
Pfizer

Completed

A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers

Healthy

United States
Pfizer

Completed

A Study Comparing Amounts of Tafamidis In The Blood Without Food

Healthy

Belgium
Pfizer

Completed

A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food

Healthy

Belgium
Pfizer

Completed

A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

Healthy Volunteers

Belgium
Pfizer

Completed

A Bioequivalence Study Comparing Two Different Tafamidis Formulations

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

TTR Cardiomyopathy

United States, Singapore, Belgium
Pfizer

Completed

Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers

TTR Cardiomyopathy

Singapore
Pfizer

Completed

Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects

Healthy

United States

3

Subscribe